NewLimit Series C: Armstrong-Backed Longevity Startup Raises $435M
TLDR: NewLimit Series C raised $435M led by Founders Fund for longevity biotech expansion and clinical readiness. Startup targets epigenetic reprogramming therapies aimed at restoring...












